clinicalomicsprowebdirectory
Facebook
Linkedin
Twitter
News
Topics
Informatics
Molecular Dx
Patient Care
Oncology
Precision Medicine
Translational Research
Magazine
Browse Issues
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Multimedia
eBooks
Webinars
Virtual Event
Learning Labs
Podcasts
Inside Precision Medicine Live
Search
Facebook
Linkedin
Twitter
Update Preferences
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Privacy Policy
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Inside Precision Medicine
News
News & Features
AbbVie Buys ImmunoGen for $10.1B to Speed Entry into Ovarian Cancer…
News & Features
Biological Robots Show Healing Potential
News & Features
ACC and AHA Issue New Guideline for Preventing and Optimally Managing…
News & Features
Slow Brain Waves: A Natural Shield against Epileptic Activity
News & Features
Nasal Swab Test Separates High- from Low-Risk Lung Cancer Polyps
Topics
Informatics
Molecular Dx
Patient Care
Oncology
Precision Medicine
Translational Research
Magazine
Browse Issues
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Multimedia
eBooks
Webinars
Virtual Event
Learning Labs
Podcasts
Inside Precision Medicine Live
Non-hodgkin's lymphoma
News & Features
Antibiotics Blunt CAR T Effect in Lymphoma Treatment
Malorye Branca
-
March 22, 2023
0
News & Features
Viruses that Cause Cancer Recruit Human Protein to Evade Immune Response
Chris Anderson
-
February 8, 2023
0
News & Features
Roche Bi-Specific Antibody Approved by FDA for a Relapsed or Refractory Form of Non-Hodgkin Lymphoma
Chris Anderson
-
December 27, 2022
0
News & Features
Single Cell Test Could Help Guide Cancer Therapy Selection
Helen Albert
-
October 15, 2021
0
News & Features
Caribou Biosciences’ IPO Hauls in $304M to Fund Development of Gene-Edited Cell Therapies
Chris Anderson
-
July 26, 2021
0
News & Features
New Class of Drugs Could Help Fight Lymphoma
Helen Albert
-
June 22, 2021
0
News & Features
New Immunotherapy Target Discovered for Non-Hodgkin Lymphoma
Chris Anderson
-
April 24, 2020
0
News & Features
Protein Inhibitor Could be New Approach for Treating Non-Hodgkin Lymphomas
Chris Anderson
-
January 8, 2020
0
Molecular Dx
Caris IDs potential Non-Hodgkins Lymphoma Drug Target
Chris Anderson
-
March 29, 2019
0
Molecular Dx
Caris IDs Mechanism of Aptamer with Potential for Treating Non-Hodgkin Lymphoma
Clinical OMICs Staff Writer
-
December 11, 2017
0
Related Content
AbbVie Buys ImmunoGen for $10.1B to Speed Entry into Ovarian Cancer and Other Solid Tumors
Understanding the Vaginal Microbiome's Impact on Health and Disease
Combination Radiation Therapy Shows Promise for Patients with Pancreatic Cancer
Nutrient Found in Red Meat and Dairy Products Could Boost Cancer Therapies
Inside Precision Medicine
![CRISPR Therapeutics and Massachusetts General Hospital Cancer Center said they will use CRISPR/Cas9 gene editing to develop novel T cell therapies for blood and solid tumors. [Source: Feng Zhang and Steve Dixo]](https://www.insideprecisionmedicine.com/wp-content/uploads/2019/01/1218.jpeg "Caribou Biosciences’ IPO Hauls in $304M to Fund Development of Gene-Edited Cell Therapies")
